Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 466

1.

Residual setup error in the canine intracranial region after megavoltage, kilovoltage, or cone-beam computed tomographic image guidance for radiation therapy.

Morimoto CY, Mayer MN, Sidhu N, Bloomfield R, Waldner CL.

Vet Comp Oncol. 2019 Aug 21. doi: 10.1111/vco.12532. [Epub ahead of print]

PMID:
31433554
2.

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis.

Hayashi M, Madokoro H, Yamada K, Nishida H, Morimoto C, Sakamoto M, Yanagawa H, Yamada T.

Cancers (Basel). 2019 Aug 8;11(8). pii: E1138. doi: 10.3390/cancers11081138.

3.

Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.

Hatano R, Itoh T, Otsuka H, Okamoto S, Komiya E, Iwata S, Aune TM, Dang NH, Kuwahara-Arai K, Ohnuma K, Morimoto C.

MAbs. 2019 Aug 18:1-15. doi: 10.1080/19420862.2019.1654305. [Epub ahead of print]

PMID:
31397631
4.

Clinical impacts of sun exposures on the faces and hands of Japanese women of different ages.

Flament F, Velleman D, Yamamoto S, Nicolas A, Udodaira K, Yamamoto S, Morimoto C, Belkebla S, Negre C, Delaunay C.

Int J Cosmet Sci. 2019 Jul 17. doi: 10.1111/ics.12555. [Epub ahead of print]

PMID:
31314913
5.

Correlation between eosinophil count, its genetic background and body mass index: The Nagahama Study.

Sunadome H, Matsumoto H, Izuhara Y, Nagasaki T, Kanemitsu Y, Ishiyama Y, Morimoto C, Oguma T, Ito I, Murase K, Muro S, Kawaguchi T, Tabara Y, Chin K, Matsuda F, Hirai T.

Allergol Int. 2019 Jul 1. pii: S1323-8930(19)30080-2. doi: 10.1016/j.alit.2019.05.012. [Epub ahead of print]

6.

Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.

Hatano R, Yamada T, Madokoro H, Otsuka H, Komiya E, Itoh T, Narita Y, Iwata S, Yamazaki H, Matsuoka S, Dang NH, Ohnuma K, Morimoto C.

PLoS One. 2019 Jun 13;14(6):e0218330. doi: 10.1371/journal.pone.0218330. eCollection 2019.

7.

CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.

Mezawa Y, Daigo Y, Takano A, Miyagi Y, Yokose T, Yamashita T, Morimoto C, Hino O, Orimo A.

Cancer Med. 2019 Jul;8(8):3936-3948. doi: 10.1002/cam4.2249. Epub 2019 May 29.

8.

Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line.

Yanagihara K, Kubo T, Iino Y, Mihara K, Morimoto C, Seyama T, Kuwata T, Ochiai A, Yokozaki H.

Oncotarget. 2019 Mar 29;10(25):2435-2450. doi: 10.18632/oncotarget.26764. eCollection 2019 Mar 29.

9.

Anti-human CD9 antibody Fab fragment impairs the internalization of extracellular vesicles and the nuclear transfer of their cargo proteins.

Santos MF, Rappa G, Karbanová J, Vanier C, Morimoto C, Corbeil D, Lorico A.

J Cell Mol Med. 2019 Jun;23(6):4408-4421. doi: 10.1111/jcmm.14334. Epub 2019 Apr 13.

10.

Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice.

Ishizawa K, Wang Q, Li J, Xu N, Nemoto Y, Morimoto C, Fujii W, Tamura Y, Fujigaki Y, Tsukamoto K, Fujita T, Uchida S, Shibata S.

J Am Soc Nephrol. 2019 May;30(5):782-794. doi: 10.1681/ASN.2018070703. Epub 2019 Mar 26.

PMID:
30914436
11.

Audiological evaluation of infants using mother's voice.

Saito O, Nishimura T, Morimoto C, Otsuka S, Uratani Y, Matsunaga Y, Hosoi H, Kitahara T.

Int J Pediatr Otorhinolaryngol. 2019 Jun;121:81-87. doi: 10.1016/j.ijporl.2019.03.005. Epub 2019 Mar 11.

PMID:
30877980
12.

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model.

Nemoto Y, Kumagai T, Ishizawa K, Miura Y, Shiraishi T, Morimoto C, Sakai K, Omizo H, Yamazaki O, Tamura Y, Fujigaki Y, Kawachi H, Kuro-O M, Uchida S, Shibata S.

Sci Rep. 2019 Feb 11;9(1):1732. doi: 10.1038/s41598-018-38389-3.

13.

Effects of repetitive transcranial magnetic stimulation on ER stress-related genes and glutamate, γ-aminobutyric acid and glycine transporter genes in mouse brain.

Ikeda T, Kobayashi S, Morimoto C.

Biochem Biophys Rep. 2018 Nov 12;17:10-16. doi: 10.1016/j.bbrep.2018.10.015. eCollection 2019 Mar.

14.

Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.

Itoh T, Hatano R, Komiya E, Otsuka H, Narita Y, Aune TM, Dang NH, Matsuoka S, Naito H, Tominaga M, Takamori K, Morimoto C, Ohnuma K.

J Invest Dermatol. 2019 Apr;139(4):878-889. doi: 10.1016/j.jid.2018.09.037. Epub 2018 Nov 10.

PMID:
30423328
15.

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma.

Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.

Blood Cancer J. 2018 Oct 22;8(11):99. doi: 10.1038/s41408-018-0127-y.

16.

Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy.

Ohnuma K, Hatano R, Dang NH, Morimoto C.

Mod Rheumatol. 2018 Oct 4:1-32. doi: 10.1080/14397595.2018.1532559. [Epub ahead of print]

PMID:
30285531
17.

Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.

Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C.

Biochem Biophys Res Commun. 2018 Oct 2;504(2):491-498. doi: 10.1016/j.bbrc.2018.08.193. Epub 2018 Sep 6.

PMID:
30197002
18.

Optimal small-molecular reference RNA for RT-qPCR-based body fluid identification.

Fujimoto S, Manabe S, Morimoto C, Ozeki M, Hamano Y, Tamaki K.

Forensic Sci Int Genet. 2018 Nov;37:135-142. doi: 10.1016/j.fsigen.2018.08.010. Epub 2018 Aug 18.

PMID:
30172170
19.

Microglia permit climbing fiber elimination by promoting GABAergic inhibition in the developing cerebellum.

Nakayama H, Abe M, Morimoto C, Iida T, Okabe S, Sakimura K, Hashimoto K.

Nat Commun. 2018 Jul 19;9(1):2830. doi: 10.1038/s41467-018-05100-z.

20.

Gene expression microarray data from mouse CBS treated with rTMS for 30 days, mouse cerebrum and CBS treated with rTMS for 40 days.

Ikeda T, Kobayashi S, Morimoto C.

Data Brief. 2018 Feb 8;17:1078-1081. doi: 10.1016/j.dib.2018.01.079. eCollection 2018 Apr.

21.

The Role of Estrogen Receptor β in the Dorsal Raphe Nucleus on the Expression of Female Sexual Behavior in C57BL/6J Mice.

Sano K, Morimoto C, Nataka M, Musatov S, Tsuda MC, Yamaguchi N, Sakamoto T, Ogawa S.

Front Endocrinol (Lausanne). 2018 May 16;9:243. doi: 10.3389/fendo.2018.00243. eCollection 2018.

22.

A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.

Ohnuma K, Hatano R, Komiya E, Otsuka H, Itoh T, Iwao N, Kaneko Y, Yamada T, Dang NH, Morimoto C.

Front Biosci (Landmark Ed). 2018 Jun 1;23:1754-1779. Review.

PMID:
29772527
23.

Emergence of Smoldering ANCA-associated Glomerulonephritis during the Clinical Course of Mixed Connective Tissue Disease and Sjögren's Syndrome.

Morimoto C, Fujigaki Y, Tamura Y, Ota T, Shibata S, Asako K, Kikuchi H, Kono H, Kondo F, Yamaguchi Y, Uchida S.

Intern Med. 2018 Jun 15;57(12):1757-1762. doi: 10.2169/internalmedicine.9844-17. Epub 2017 Dec 21.

24.

Discrimination of relationships with the same degree of kinship using chromosomal sharing patterns estimated from high-density SNPs.

Morimoto C, Manabe S, Fujimoto S, Hamano Y, Tamaki K.

Forensic Sci Int Genet. 2018 Mar;33:10-16. doi: 10.1016/j.fsigen.2017.11.010. Epub 2017 Nov 22.

PMID:
29172066
25.

Gene expression microarray data from mouse cerebrum treated with rTMS for 30 days.

Ikeda T, Kobayashi S, Morimoto C.

Data Brief. 2017 Oct 19;15:948-969. doi: 10.1016/j.dib.2017.10.034. eCollection 2017 Dec.

26.

Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence.

Fujigaki Y, Morimoto C, Iino R, Taniguchi K, Kawamorita Y, Asakawa S, Toyoki D, Miyano S, Fujii W, Ota T, Shibata S, Uchida S.

Case Rep Nephrol. 2017;2017:7143649. doi: 10.1155/2017/7143649. Epub 2017 Oct 11.

27.

Sensitization to Staphylococcus aureus enterotoxins in smokers with asthma.

Nagasaki T, Matsumoto H, Oguma T, Ito I, Inoue H, Iwata T, Tajiri T, Kanemitsu Y, Izuhara Y, Morimoto C, Ishiyama Y, Sunadome H, Niimi A, Hirai T.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):408-414.e2. doi: 10.1016/j.anai.2017.08.001.

PMID:
29150068
28.

Development and validation of open-source software for DNA mixture interpretation based on a quantitative continuous model.

Manabe S, Morimoto C, Hamano Y, Fujimoto S, Tamaki K.

PLoS One. 2017 Nov 17;12(11):e0188183. doi: 10.1371/journal.pone.0188183. eCollection 2017.

29.
30.

Identification of senescent cell surface targetable protein DPP4.

Kim KM, Noh JH, Bodogai M, Martindale JL, Yang X, Indig FE, Basu SK, Ohnuma K, Morimoto C, Johnson PF, Biragyn A, Abdelmohsen K, Gorospe M.

Genes Dev. 2017 Aug 1;31(15):1529-1534. doi: 10.1101/gad.302570.117. Epub 2017 Sep 6.

31.

Forensic age prediction for saliva samples using methylation-sensitive high resolution melting: exploratory application for cigarette butts.

Hamano Y, Manabe S, Morimoto C, Fujimoto S, Tamaki K.

Sci Rep. 2017 Sep 5;7(1):10444. doi: 10.1038/s41598-017-10752-w.

32.

Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.

Xiao X, Yang H, Arutiunian V, Fang Y, Besse G, Morimoto C, Zirkle B, Chen XS.

Nucleic Acids Res. 2017 Jul 7;45(12):7540. doi: 10.1093/nar/gkx564. No abstract available.

33.

Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.

Xiao X, Yang H, Arutiunian V, Fang Y, Besse G, Morimoto C, Zirkle B, Chen XS.

Nucleic Acids Res. 2017 Jul 7;45(12):7494-7506. doi: 10.1093/nar/gkx362. Erratum in: Nucleic Acids Res. 2017 Jul 7;45(12 ):7540.

34.

A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.

Komiya E, Hatano R, Otsuka H, Itoh T, Yamazaki H, Yamada T, Dang NH, Tominaga M, Suga Y, Kimura U, Takamori K, Morimoto C, Ohnuma K.

J Dermatol Sci. 2017 Jun;86(3):212-221. doi: 10.1016/j.jdermsci.2017.03.005. Epub 2017 Mar 10.

PMID:
28365081
35.

Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.

Asakawa S, Shibata S, Morimoto C, Shiraishi T, Nakamura T, Tamura Y, Kumagai T, Hosoyamada M, Uchida S.

Oxid Med Cell Longev. 2017;2017:3759153. doi: 10.1155/2017/3759153. Epub 2017 Feb 28.

36.

Matching pairs difficulty in children with spinal muscular atrophy type I.

Polido GJ, Barbosa AF, Morimoto CH, Caromano FA, Favero FM, Zanoteli E, Reed UC, Voos MC.

Neuromuscul Disord. 2017 May;27(5):419-427. doi: 10.1016/j.nmd.2017.01.017. Epub 2017 Feb 15.

PMID:
28302390
37.

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.

Angevin E, Isambert N, Trillet-Lenoir V, You B, Alexandre J, Zalcman G, Vielh P, Farace F, Valleix F, Podoll T, Kuramochi Y, Miyashita I, Hosono O, Dang NH, Ohnuma K, Yamada T, Kaneko Y, Morimoto C.

Br J Cancer. 2017 Apr 25;116(9):1126-1134. doi: 10.1038/bjc.2017.62. Epub 2017 Mar 14.

38.

Suturing method as a factor for uterine vascularity after laparoscopic myomectomy.

Fujimoto A, Morimoto C, Hosokawa Y, Hasegawa A.

Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:146-149. doi: 10.1016/j.ejogrb.2017.02.027. Epub 2017 Feb 28.

PMID:
28260688
39.

Initiatives for community building in an urban semi-marginal village: Progress of the Ajinadai Lively Project and future challenges.

Masaki N, Matsubara M, Hayashi S, Fukuizumi M, Morimoto C, Mori M.

Nihon Koshu Eisei Zasshi. 2016;63(12):750-757. doi: 10.11236/jph.63.12_750. Japanese.

40.

Role of IL-26+CD26+CD4 T Cells in Pulmonary Chronic Graft-Versus-Host Disease and Treatment with Caveolin-1-Ig Fc Conjugate.

Ohnuma K, Hatano R, Itoh T, Iwao N, Dang NH, Morimoto C.

Crit Rev Immunol. 2016;36(3):239-267. doi: 10.1615/CritRevImmunol.2016018772. Review.

PMID:
28008806
41.

Effects of noise exposure on neonatal auditory brainstem response thresholds in pregnant guinea pigs at different gestational periods.

Morimoto C, Nario K, Nishimura T, Shimokura R, Hosoi H, Kitahara T.

J Obstet Gynaecol Res. 2017 Jan;43(1):78-86. doi: 10.1111/jog.13194. Epub 2016 Dec 9.

PMID:
27935161
42.

Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections.

Ikeda T, Fragiadaki M, Shi-Wen X, Ponticos M, Khan K, Denton C, Garcia P, Bou-Gharios G, Yamakawa A, Morimoto C, Abraham D.

Data Brief. 2016 Aug 10;8:1377-80. doi: 10.1016/j.dib.2016.08.014. eCollection 2016 Sep.

43.

Forensic age prediction for dead or living samples by use of methylation-sensitive high resolution melting.

Hamano Y, Manabe S, Morimoto C, Fujimoto S, Ozeki M, Tamaki K.

Leg Med (Tokyo). 2016 Jul;21:5-10. doi: 10.1016/j.legalmed.2016.05.001. Epub 2016 May 7.

PMID:
27497326
44.

Pairwise Kinship Analysis by the Index of Chromosome Sharing Using High-Density Single Nucleotide Polymorphisms.

Morimoto C, Manabe S, Kawaguchi T, Kawai C, Fujimoto S, Hamano Y, Yamada R, Matsuda F, Tamaki K.

PLoS One. 2016 Jul 29;11(7):e0160287. doi: 10.1371/journal.pone.0160287. eCollection 2016.

45.

[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule].

Morimoto C, Ohnuma K.

Gan To Kagaku Ryoho. 2016 Jul;43(7):855-62. Review. Japanese.

PMID:
27431629
46.

Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts.

Ikeda T, Fragiadaki M, Shi-Wen X, Ponticos M, Khan K, Denton C, Garcia P, Bou-Gharios G, Yamakawa A, Morimoto C, Abraham D.

Biochem Biophys Rep. 2016 Jul 2;7:246-252. doi: 10.1016/j.bbrep.2016.06.022. eCollection 2016 Sep.

47.

Establishment of anti-mesothelioma monoclonal antibodies.

Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O.

BMC Res Notes. 2016 Jun 24;9:324. doi: 10.1186/s13104-016-2128-x.

48.

Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis.

Omata Y, Nakamura S, Koyama T, Yasui T, Hirose J, Izawa N, Matsumoto T, Imai Y, Seo S, Kurokawa M, Tsutsumi S, Kadono Y, Morimoto C, Aburatani H, Miyamoto T, Tanaka S.

PLoS One. 2016 Jun 23;11(6):e0157992. doi: 10.1371/journal.pone.0157992. eCollection 2016.

49.

Evaluation of the global DNA methylation in canine mast cell tumour samples by immunostaining of 5-methyl cytosine.

Morimoto CY, Tedardi MV, da Fonseca IIM, Kimura KC, Sanches DS, Epiphanio TF, de Francisco Strefezzi R, Dagli MLZ.

Vet Comp Oncol. 2017 Sep;15(3):1014-1018. doi: 10.1111/vco.12241. Epub 2016 May 3.

PMID:
27140659
50.

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition.

Hayashi M, Madokoro H, Yamada K, Nishida H, Morimoto C, Sakamoto M, Yamada T.

Cancer Cell Int. 2016 Apr 30;16:35. doi: 10.1186/s12935-016-0310-9. eCollection 2016.

Supplemental Content

Loading ...
Support Center